Global Gonorrhea Therapeutics Market 2017-2021

淋病治療薬の世界市場2017-2021:単独療法、併用療法

◆タイトル:Global Gonorrhea Therapeutics Market 2017-2021
◆商品コード:IRTNTR15264
◆調査・発行会社:Technavio (Infiniti Research Ltd.)
◆発行日:2017年10月24日
◆ページ数:79
◆資料形式:PDF / 英語
◆納品方法:Eメール(受注後24時間以内)
◆調査対象地域:グローバル
◆産業分野:医療・バイオ・製薬
◆販売価格オプション(消費税別)
Single User(1名利用)USD3,500 ⇒換算¥395,500見積依頼/購入/質問フォーム
Five User(~5名利用)USD4,000 ⇒換算¥452,000見積依頼/購入/質問フォーム
Enterprise License(全社内共有可)USD5,000 ⇒換算¥565,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※商品の納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(振込先:三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※ご購入後、資料に記載の英語表現や単語の意味に関しましては無料でお答えいたします。(但し、対応範囲は弊社で判断)
※弊社H&Iグローバルリサーチ株式会社はTechnavio (Infiniti Research Ltd.)の日本における正規販売代理店です。

【資料の概要】

Technavio社が発行した当調査レポートでは、淋病治療薬の世界市場について調査・分析し、エグゼクティブサマリー、市場概観、市場概観、業界の構造分析、淋病治療薬の世界市場規模及び予測、用途別分析、地域別分析/市場規模、主要国別分析、市場の成長要因、市場の課題、市場動向、競争状況、主要企業(ベンダー)分析などの情報をお届けいたします。Technavio社は淋病治療薬の世界市場が2017-2021年期間中に年平均2.88%成長すると予測しています。当レポート上に記載されている主な企業は、Bharat Pharmaceuticals、GlaxoSmithKline、Merck、Pfizer等です。

About Gonorrhea Therapeutics
Gonorrhea is a sexually transmitted disease (STD) that affects both men and women. The infection affects the genitals, rectum, and the throat. The treatment landscape typically involves the use of antibiotics with dual therapy dominating the market compared with monotherapy. As the market has a deep penetration of generics, the growth rate is expected to be moderate during the forecast period. Additionally, the advent of new antibiotic-resistant strains will continue to hinder the growth prospects.

Technavio’s analysts forecast the global gonorrhea therapeutics market to grow at a CAGR of 2.88% during the period 2017-2021.

[Covered in this report]
The report covers the present scenario and the growth prospects of the global gonorrhea therapeutics market for 2017-2021. To calculate the market size, the report considers the sales of branded, generic, and off-label drugs.

The market is divided into the following segments based on geography:
• Americas
• APAC
• EMEA

Technavio’s report, Global Gonorrhea Therapeutics Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

[Key vendors]
• Bharat Pharmaceuticals
• GlaxoSmithKline
• Merck
• Pfizer

[Other prominent vendors]
• Alopexx Pharmaceuticals
• AstraZeneca
• Cempra
• Debiopharm Group
• Melinta Therapeutics

[Market driver]
• Rising prevalence of disease
• For a full, detailed list, view our report

[Market challenge]
• Emergence of antibiotic-resistant gonococcal strain
• For a full, detailed list, view our report

[Market trend]
• Advent of vaccine for prevention of gonorrhea
• For a full, detailed list, view our report

[Key questions answered in this report]
• What will the market size be in 2021 and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?

*** You can request one free hour of our analyst’s time when you purchase this market report. Details are provided within the report.

【資料の目次】

Table of Contents
PART 01: EXECUTIVE SUMMARY

PART 02: SCOPE OF THE REPORT

PART 03: RESEARCH METHODOLOGY

PART 04: INTRODUCTION
• Market outline

PART 05: GONORRHEA: A BRIEF INTRODUCTION
• What is gonorrhea?
• What causes gonorrhea?
• What are the various symptoms of gonorrhea?
• How is gonorrhea treated?

PART 06: MARKET LANDSCAPE
• Market overview
• Market size and forecast
• Five forces analysis

PART 07: PIPELINE

PART 08: MARKET SEGMENTATION BY APPLICATION
• Monotherapy
• Market size and forecast
• Dual therapy
• Market size and forecast

PART 09: REGIONAL LANDSCAPE
• Geographical segmentation
• Regional comparison
• Americas – Market size and forecast
• EMEA – Market size and forecast
• APAC – Market size and forecast
• Key leading countries
• Market opportunity

PART 10: DECISION FRAMEWORK

PART 11: DRIVERS AND CHALLENGES
• Market drivers
• Market challenges

PART 12: MARKET TRENDS
• Rising government initiatives to combat antibiotic resistance
• Advent of vaccine for prevention of gonorrhea
• Expedited Partner Therapy (EPT)

PART 13: VENDOR LANDSCAPE
• Competitive landscape

PART 14: KEY VENDOR ANALYSIS
• Bharat Pharmaceuticals
• GlaxoSmithKline
• Merck
• Pfizer
• Other prominent vendors

PART 15: APPENDIX
• List of abbreviations

[List of Exhibits]
Exhibit 01: Incidence rate of gonorrhea in US, 2008 (per 100,000 population)
Exhibit 02: Symptoms of gonorrhea
Exhibit 03: Global gonorrhea therapeutics market: Snapshot
Exhibit 04: Global gonorrhea therapeutics market, 2016-2021 ($ millions)
Exhibit 05: Opportunity analysis of global gonorrhea therapeutics market
Exhibit 06: Five forces analysis
Exhibit 07: Key clinical trials
Exhibit 08: Global gonorrhea therapeutics market: Segmentation by application
Exhibit 09: Global gonorrhea therapeutics market share by application, 2016
Exhibit 10: Global gonorrhea monotherapy therapeutics market, 2016-2021 ($ millions)
Exhibit 11: Global gonorrhea dual therapy therapeutics market, 2016-2021 ($ millions)
Exhibit 12: Global gonorrhea therapeutics market share by region, 2016 and 2021
Exhibit 13: Global gonorrhea therapeutics market revenue by region, 2016-2021 ($ millions)
Exhibit 14: Global gonorrhea therapeutics market share by region, 2016-2021
Exhibit 15: Regional comparison
Exhibit 16: Gonorrhea therapeutics market in Americas 2016-2021 ($ millions)
Exhibit 17: Gonorrhea therapeutics market in EMEA 2016-2021 ($ millions)
Exhibit 18: Gonorrhea therapeutics market in APAC 2016-2021 ($ millions)
Exhibit 19: Key leading countries
Exhibit 20: Travel associated gonorrhea cases by region, 2008-2013
Exhibit 21: Prevalence rate of gonorrhea, 2009
Exhibit 22: Prevalence rate of gonorrhea by age and race
Exhibit 23: Infertility ratio in males and females
Exhibit 24: Revenue history for Zithromax/Zmax, 2005-2016
Exhibit 25: Pictorial presentation of EPT
Exhibit 26: Competitive structure analysis of global antibiotics market 2016
Exhibit 27: Bharat Pharmaceuticals: Strength assessment
Exhibit 28: Bharat Pharmaceuticals: Strategy assessment
Exhibit 29: Bharat Pharmaceuticals: Opportunity assessment
Exhibit 30: GlaxoSmithKline: Key highlights
Exhibit 31: GlaxoSmithKline: Strength assessment
Exhibit 32: GlaxoSmithKline: Strategy assessment
Exhibit 33: GlaxoSmithKline: Opportunity assessment
Exhibit 34: Merck: Key highlights
Exhibit 35: Merck: Strength assessment
Exhibit 36: Merck: Strategy assessment
Exhibit 37: Merck: Opportunity assessment
Exhibit 38: Pfizer: Key highlights
Exhibit 39: Pfizer: Strength assessment
Exhibit 40: Pfizer: Strategy assessment
Exhibit 41: Pfizer: Opportunity assessment



【掲載企業】

Bharat Pharmaceuticals, GlaxoSmithKline, Merck, Pfizer, Alopexx Pharmaceuticals, AstraZeneca, Cempra, Debiopharm Group, and Melinta Therapeutics.


★調査レポート[淋病治療薬の世界市場2017-2021:単独療法、併用療法] (Global Gonorrhea Therapeutics Market 2017-2021 / IRTNTR15264)販売に関する免責事項
[淋病治療薬の世界市場2017-2021:単独療法、併用療法] (Global Gonorrhea Therapeutics Market 2017-2021 / IRTNTR15264)についてEメールでお問い合わせ


◆H&Iグローバルリサーチ株式会社のお客様(例)◆